Status:
COMPLETED
A Prospective Observational Study of the Clinical Performance of Femplant in Pakistan
Lead Sponsor:
FHI 360
Collaborating Sponsors:
United States Agency for International Development (USAID)
Conditions:
Contraception
Eligibility:
FEMALE
18-44 years
Brief Summary
This will be a non-comparative prospective observational study of women using Femplant as a primary method of contraception in Pakistan.
Detailed Description
This will be a non-comparative prospective observational study of women using Femplant as a primary method of contraception in Pakistan. It will be conducted in close collaboration with the Pakistan M...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- To be eligible for inclusion, a woman must:
- be aged 18-44 years, inclusive
- be willing to sign an informed consent document
- agree to return for follow-up visits
- have decided to receive Femplant as a method of contraception and met the clinic criteria for eligibility of this method of contraception
Exclusion
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
724 Patients enrolled
Trial Details
Trial ID
NCT01463254
Start Date
October 1 2011
End Date
February 1 2013
Last Update
July 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marie Stopes Society clinics
Pakistan, Pakistan, Pakistan